• Login
    View Item 
    •   UMB Digital Archive
    • School, Graduate
    • Theses and Dissertations All Schools
    • View Item
    •   UMB Digital Archive
    • School, Graduate
    • Theses and Dissertations All Schools
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of UMB Digital ArchiveCommunitiesPublication DateAuthorsTitlesSubjectsThis CollectionPublication DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Statistics

    Display statistics

    The synergistic effect of anti-androgens and signal transduction inhibitors in prostate cancer progression

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Find Full text
    Author
    Schayowitz, Adam B.
    Advisor
    Brodie, Angela
    Date
    2008
    Type
    dissertation
    
    Metadata
    Show full item record
    Abstract
    Androgen ablation is the standard treatment for advanced disease. Despite initial success, approximately 70% of patients eventually progress to hormone refractory prostate cancer (HRPC). To investigate the mechanisms of this resistance we utilized human prostate cancer cells (LNCaP) to create a hormone refractory prostate cancer (HRPC) model which mimics disease progression (HP-LNCaP). Our novel anti-androgen/androgen synthesis inhibitor, VN/124-1, proved to be a potent inhibitor of proliferation and AR activation in hormone dependent and hormone refractory prostate cancer cell lines (HP-LNCaP). Anti-androgen treatment also resulted in increased expression of multiple signal transduction pathways (STPs). However, compared to hormone sensitive cells, resistant cells demonstrated a higher level of STPs. Inhibition of STPs such as mTOR and EGFR in resistant cells resulted in decreased protein expression and increased AR expression and activation. These findings demonstrated that a compensatory signaling mechanism and cross-talk between AR and PI3K/Akt/mTOR pathways occurs with androgen ablation in vitro. As such, we investigated the effect of dual inhibition and found that combination treatment with VN/124-1 and everolimus (mTOR inhibitor) or gefitinib (EGFR/HER-2 inhibitor), caused significant inhibition of cell proliferation in our HRPC model. We further analyzed the interaction of the AR and mTOR pathways. Using co-immunoprecipitation of Akt and AR, it was found that the interaction between the pathways increases 7-fold as cells progressed from a hormone sensitive to hormone resistant model. The interaction was reduced dramatically with VN/124-1 plus everolimus. Our in vitro findings were supported by xenograft investigations. The addition of everolimus to bicalutamide treatment of resistant tumors significantly decreased growth rate and tumor volume compared to single agent bicalutamide (p=0.0001) or everolimus (p=0.04). Analysis of tumors demonstrated that anti-androgen treatment increased IGFR, p-Akt, p-70S6K and p-P6S6 protein expression compared to control xenografts. In summary, as tumors progress on anti-androgen therapy, there is an increase in signal transduction pathway activation compared to controls. As such, the combination of anti-androgen, VN/124-1, and mTOR inhibitors from the beginning significantly reduced tumor volume compared to everolimus or bicalutamide alone in HRPC xenografts.
    Description
    University of Maryland, Baltimore. Pharmacology and Experimental Therapeutics. Ph.D. 2008
    Keyword
    Health Sciences, Pharmacology
    Identifier to cite or link to this item
    http://hdl.handle.net/10713/978
    Collections
    Theses and Dissertations All Schools
    Theses and Dissertations School of Medicine

    entitlement

     
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Policies | Contact Us | UMB Health Sciences & Human Services Library
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.